Superior efficacy of neoadjuvant chemotherapy and radical cystectomy in cT3-4aN0M0 compared to cT2N0M0 bladder cancer.

Hermans, T J N; Voskuilen, C S; Deelen, M; Mertens, L S; Horenblas, S; Meijer, R P; Boormans, J L; Aben, K K; van der Heijden, M S; Pos, F J; de Wit, R; Beerepoot, L V; Verhoeven, R H A; van Rhijn, B W G

Hermans, T J N; Voskuilen, C S; Deelen, M; Mertens, L S; Horenblas, S; Meijer, R P; Boormans, J L; Aben, K K; van der Heijden, M S; Pos, F J; de Wit, R; Beerepoot, L V; Verhoeven, R H A; van Rhijn, B W G.

Afiliación

Hermans TJN; Department of Surgical Oncology, Division of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Voskuilen CS; Department of Surgical Oncology, Division of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Deelen M; Department of Surgical Oncology, Division of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Mertens LS; Department of Surgical Oncology, Division of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Horenblas S; Department of Surgical Oncology, Division of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Meijer RP; Department of Surgical Oncology, Division of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Boormans JL; Department of Urology, University Medical Center Utrecht, Utrecht, The Netherlands.
Aben KK; Department of Urology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
van der Heijden MS; Department of Research, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands.
Pos FJ; Department for Health Evidence, Radboud University Medical Centre, Nijmegen, The Netherlands.
de Wit R; Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Beerepoot LV; Department of Radiation Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Verhoeven RHA; Department of Medical Oncology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
van Rhijn BWG; Department of Medical Oncology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands.

Int J Cancer ; 144(6): 1453-1459, 2019 03 15.

Article en En | MEDLINE | ID: mdl-30155893

Asunto(s)

Antineoplásicos/uso terapéutico; Carcinoma de Células Transicionales/terapia; Cistectomía; Sistema de Registros/estadística & datos numéricos; Neoplasias de la Vejiga Urinaria/terapia; Anciano; Carcinoma de Células Transicionales/mortalidad; Carcinoma de Células Transicionales/patología; Supervivencia sin Enfermedad; Femenino; Humanos; Estimación de Kaplan-Meier; Masculino; Persona de Mediana Edad; Terapia Neoadyuvante/métodos; Estadificación de Neoplasias; Países Bajos/epidemiología; Vejiga Urinaria/patología; Vejiga Urinaria/cirugía; Neoplasias de la Vejiga Urinaria/mortalidad; Neoplasias de la Vejiga Urinaria/patología

Palabras clave

muscle-invasive bladder cancer; neoadjuvant chemotherapy; neoadjuvant radiotherapy; radical cystectomy; survival

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / Cistectomía / Sistema de Registros / Antineoplásicos Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Int J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google